Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 31 references without a DOI — listed, not checked
no DOI — not checkedref1
no DOI — not checkedBristol-Myers Squibb, Glaxo Wellcome (now GlaxoSmithKline), Merck, and F. Hoffmann-La Roche. Later, Abbott and Pfizer also joined the initiative
no DOI — not checkedNew Public/Private Sector Effort Initiated to Accelerate Access to HIV/AIDS Care and Treatment in Developing Countries
no DOI — not checkedref4
no DOI — not checkedref5
no DOI — not checkedref6
no DOI — not checkedIndia and the Drug Patent Wars
no DOI — not checkedref8
no DOI — not checkedref9
no DOI — not checkedPharmaceutical Market Access and Drug Safety Act of 2007, S 242, 110th Cong., 1st sess
no DOI — not checkedPlan to Import Drugs from Canada Passes in Senate, but Bush Declines to Carry It Out
no DOI — not checkedThe Campaign: What Is the Campaign?" available at www.accessmed-msf.org/ campaign/campaign.shtm
no DOI — not checkedThe Economics of Price Regulation and Innovation
no DOI — not checkedTufts Center for the Study of Drug Development Pegs Cost of a New Prescription Medicine at $802 Million," news release
no DOI — not checked19. Being able to charge different prices in different markets depends on the conditions in each market, not on the ability to charge higher prices in one market as a condition for giving a discount in another market-the "cost-shifting" that is often alleged. See Michael A. Morrisey, Cost Shifting in Health Care: Separating Evidence from Rhetoric
no DOI — not checked22. Market power exists when there are no readily available, equally satisfactory substitutes for the good or service that the seller is offering. See Terry Fisher
no DOI — not checkedref20
no DOI — not checkedEuropeans Investigate Resale of AIDS Drugs
no DOI — not checkedActual prices may be higher due to local price inflators, such as the need to pay a local agent, taxes and tariffs
no DOI — not checkedAgain Reduces Price of STOCRIN (efavirenz) for Patients in Least Developed Countries and Countries Hardest Hit by Epidemic
no DOI — not checkedMerck and Co. to Distribute ATRIPLA in Developing Countries
no DOI — not checkedAbbott Announces Kaletra Price Cut for Lower Middle-Income Countries, Makes New Offer to Thailand
no DOI — not checkedThailand and the Drug Patent Wars
no DOI — not checkedBrazilian Health Ministry Rejects Merck's Offer to Sell Antiretroviral at Discounted Price; Government to Decide about Compulsory License
no DOI — not checkedLesson from Brazil: Pharma Needs to Explain Its Pricing
no DOI — not checkedFor the past three years, the Thai government claimed the drugs produced in this plant were good, even though the World Health Organization, the Global Fund
no DOI — not checkedThai Government Expands Scope of Patent-Breaking Strategy amid Unrest in Asia
no DOI — not checkedref36
no DOI — not checkedGovernment-Controlled Pharmaceutical Research and Development: A Recipe for Disaster
no DOI — not checkedSolving the Drug Dilemma
no DOI — not checkedA New Trade Framework for Global Healthcare R&D
checked 2026-08-28 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.